维普期刊资源整合服务平台（V6.5）

207篇 您的检索式：作者名="RESTIFO NP"

选中清除导出查看参考文献查看引证文献引用追踪共11页首页上一页第1页下一页末页 /11 跳转

	题名	作者	年代	出处	被引量
1	Does IL-17 promote tumor growth 显示文摘	Muranski P Restifo NP	2009	Blood2009，114，2：	1
2	Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice显示文摘	Feldman AL Restifo NP Alexander HR	2000	Cancer Res2000，60，6：	1
3	Adoptive immunotherapy for cancer:harnessing the T cell response 显示文摘	Restifo NP Dudley ME Rosenberg SA	2012	Nat Rev Immunol2012，12，4：	1
4	Less is more: lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell- based anti-tumor immunotherapy显示文摘	Wrzesinski C Restifo NP	2005	Curr Opin Immunol2005，17，2：	1
5	Not so Fas:Re-evaluating the mechanisms of immune privilege and tumor escape 显示文摘	Restifo NP	2000	Nat Med2000，6，5：	1
6	Sorting lhrougb subsets : which T-cell populations mediate highly effective adoptive im- munotherapy? 显示文摘	Klebanoff CA Gattinoni L Restifo NP	2012	J Imnmnother2012，35，9：	1
7	Adoptive cell transfer as personalized immunotherapy for human cancer显示文摘	Rosenberg SA Restifo NP	2015	Science2015，348，6230：	1
8	Cellular constituents of im- mune escape within the tumor microenvironment 显示文摘	Kerkar SP Restifo NP	2012	Cancer Res2012，72，13：	1
9	Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function 显示文摘	Palmer DC Restifo NP	2009	Trends Immunol2009，30，12：	1
10	Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice显示文摘	Feldman AL Restifo NP Alexander HR	2000	Cancer Res2000，60，6：	1
11	Cellular constituents of immune es- cape within the tumor microenvironment 显示文摘	Kerkar SP Restifo NP	2012	Cancer Res2012，72，13：	1
12	Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice显示文摘	Feldman AL Restifo NP Alexander HR	2000	Cancer Res2000，60，6：	1
13	Cancer immunotherapy: moving beyond current vaccines 显示文摘	Rosenberg SA Yang JC Restifo NP	2004	Nat Med2004，10，9：	1
14	Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic Endostatin levels in mice 显示文摘	Feldman AL Restifo NP Alexander HR	2000	Cancer Res2000，60，：	1
15	DNA and RNA - based vaccines: principles, progress and prospects 显示文摘	Leitner WW Ying H Restifo NP	1999	Vaccine1999，18，910：	1
16	Countering the 'counterattack' hypothesis 显示文摘		2001	Nature Med2001，7，3：	1
17	Natural selection of tumor variants in the genera- tion of 'tumor escape' phenotypes 显示文摘	Khong HT Restifo NP	2002	Nat Immunol2002，3，11：	1
18	Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to evaluate systemic endostatin levels in mice 显示文摘	Feldman AL Restifo NP Alexander HR	2000	Cancer Res2000，60，6：	1
19	T(H)17 cells in tumour immunity and immunotherapy显示文摘	Zou W Restifo NP	2010	Nat Rev Immunol2010，10，4：	1
20	Cellular constituents of immune escape within the tumor microenvironment显示文摘	Kerkar SP Restifo NP	2012	Cancer Res2012，72，13：	1

返回顶部每页显示：

共11页首页上一页第1页下一页末页 /11 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示